Finger prick could replace needle for breast cancer drug monitoring
NCT ID NCT07491380
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This study aims to see if a simple finger-prick blood test can accurately measure levels of certain breast cancer drugs (CDK4/6 inhibitors) compared to standard blood draws from a vein. About 90 breast cancer patients currently taking these drugs will provide both types of blood samples. If the finger-prick method proves reliable, it could make drug monitoring more convenient and less invasive for patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Curie
NOT_YET_RECRUITINGSaint-Cloud, 92210, France
-
Institut Curie Paris
RECRUITINGParis, 75005, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?